Aktualnie znajdujesz się na:

The signing of the MoU on cooperation between MRA and Ruđer Bošković Institute

On November 9, in Zagreb, the Polish-Croatian Memoradum of Understanding on strengthening comprehensive regional cooperation was signed. The main aim of the MoU is to initiate collaboration between both sides to establish the Health Innovation Hub Network.

The MoU was concluded between the Medical Research Agency, represented by the Agency's President, Mr. Radosław Sierpiński MD, PhD and Ruđer Bošković Institute, represented by the Director General of the Institute, Dr. David Metthew Smith.

 - Today's ceremony marks the beginning of a broader Polish-Croatian cooperation in the field of health. I am particularly pleased that together with such a recognised institution as Ruđer Bošković Institute we will be working closely to make our part of Europe more innovative and competitive - said President Radosław Sierpiński during the ceremony.

The MRA’ President emphasized that the purpose of this MoU is to strengthen the comprehensive regional cooperation, in particular by initiating efforts to establish Health Innovation Hub Network, which will serve as a platform of collaboration and coordination between public and private stakeholders from countries across CEE.

- The Medical Research Agency has been working for the last few months to make the idea of establishing a regional hub for innovation in health come true. I believe that joint efforts with the Croatian side, but also with other countries in the region, will bring tangible results in the near future, recalled President Sierpiński.

The signing of the MoU was preceded by talks with the management of Ruđer Bošković Institute on future cooperation. The previous experience in building public-private partnerships and possible joint actions regarding European funds was also exchanged.

The ceremony was also attended by representatives of Croatian ministries of health, science and education, economy and sustainable development.

Croatia is the another country with which the Medical Research Agency has signed such a MoU.

Options

go up